Change in Policy at FDA May Result in Improved Drug Safety

On June 30, 2008, the Food and Drug Administration (FDA) shifted authority on drug safety regulatory issues from the Office of New Drugs (OND) to a shared responsibility between OND and the Office of Surveillance and Epidemiology (OSE). Under the new policy, the drug review and drug safety offices will share equal responsibility on “significant […]

Real Health Advertising

Direct-to-Consumer marketing has its benefitsOver the years, I’ve been on all sides of health care, including a stint directing the Pfizer Medical Humanities Initiative (PMHI). In this role, I worked to leverage the knowledge, assets and resources of a Fortune 10 company to advantage the broader interests of health consumers and the professionals who cared […]